...
首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Clinical Observation of Three Dimensional Conformal Radiotherapy with Tamoxifen in Treatment of Postoperative Malignant Glioma
【24h】

Clinical Observation of Three Dimensional Conformal Radiotherapy with Tamoxifen in Treatment of Postoperative Malignant Glioma

机译:他莫昔芬三维适形放疗治疗术后恶性胶质瘤的临床观察

获取原文
           

摘要

Objective: To evaluate the efficacy and adverse effects of three dimensional conformal radiotherapy (3D-CRT)with tamoxifen in treating patients with postoperative malignant glioma. Patients and Methods: 60 patients ofpostoperative malignant glioma were randomly assigned into two groups, 30 patients were treated with 3D-CRTplus tamoxifen (treatment group), and the other 30 patients with 3D-CRT plus temozolomide (control group).All patients were radiated by 6MV X-ray, 2.0Gy per fraction, once daily, with a total dose (DT) of 56~60Gy.Tamoxifen was delivered at 60mg /m2/d, temozolomide was given at 75mg/m2/d. All patients were treated withconcurrent radiotherapy. Results: One, 2, 3 year survival rates of treatment and control group were 63.3%,30.0%, 23.0% and 70.0%, 33.3%, 26.7%, respectively (χ2=0.01, 0.23, 0.09, P>0.05). The rate of thromboembolismin treatment group was 6.7%. Conclusion: Therapeutic efficacy of two groups was similar, but it was more costeffectivein treatment group, and toxicity did not increase.
机译:目的:评价他莫昔芬三维保形放射治疗(3D-CRT)术后恶性神经胶质瘤的疗效和不良反应。患者与方法:将60例术后恶性神经胶质瘤患者随机分为两组,其中30例接受3D-CRT加他莫昔芬治疗(治疗组),其余30例接受3D-CRT加替莫唑胺治疗(对照组)。通过6MV X射线,每天一次,每次2.0Gy,总剂量(DT)为56〜60Gy。他莫昔芬的释放量为60mg / m2 / d,替莫唑胺的剂量为75mg / m2 / d。所有患者均接受同步放疗。结果:治疗组和对照组的1,2,3年生存率分别为63.3%,30.0%,23.0%和70.0%,33.3%,26.7%(χ2= 0.01、0.23、0.09,P> 0.05)。血栓栓塞素治疗组的发生率为6.7%。结论:两组疗效相似,但在治疗组中更具成本效益,且毒性并未增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号